Office of Emergency Medical Services
DEPARTMENT OF PUBLIC HEALTH
COMMONWEALTH OF MASSACHUSETTS
Voluntary Recall: Hospira Issues Recall of Two Lots of Diazepam Injection, USP
The Department has been alerted that Hospira, Inc., a Pfizer Company, has announced it is voluntarily recalling two lots of Diazepam Injection, USP. According to the company, this recall action is being initiated due to a potential for the presence of crystallized Diazepam adhered to the plunger or wall of the Carpuject. The notice states that administration of product that contains particulate may result in localized inflammation, phlebitis, low-level allergic response, thromboembolic events or immune response. The company states likelihood of serious patient harm is considered negligible.
Attached please find full information about this recall and instructions for follow up if your ambulance service has any of these lots of Diazepam Injection products.